Indication
Suicidal behavior in schizoaffective disorder
Suicidal behavior in schizoaffective disorder represents a high-risk psychiatric clinical state characterized by active or recurrent suicidal ideation, preparatory acts, and non-fatal or fatal intentional self-harm occurring in individuals diagnosed with schizoaffective disorder. Read more about Suicidal behavior in schizoaffective disorder
25 drugs 20 manufacturers
Drugs that treat it
Common Suicidal behavior in schizoaffective disorder therapies.
CLOZAPINE
CLOZAPINE
CLOZAPINE
CLOZAPINE ODT (clozapine)
CLOZARIL (clozapine)
CLOZAPINE
VERSACLOZ (clozapine)
CLOZAPINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSuicidal behavior in schizoaffective disorder represents a high-risk psychiatric clinical state characterized by active or recurrent suicidal ideation, preparatory acts, and non-fatal or fatal intentional self-harm occurring in individuals diagnosed with schizoaffective disorder.
Affecting the central nervous system and behavioral regulation in individuals experiencing concurrent psychotic and major affective disturbances, it is clinically defined by severe depressive or mixed mood episodes interacting with psychotic phenomena, such as persecutory delusions or command hallucinations.
Pathophysiologically, this presentation stems from complex neurobiological dysregulation involving monoaminergic neurotransmission—most notably serotonergic and dopaminergic pathways—alongside frontolimbic network dysfunction that impairs impulse control, cognitive processing, and affective resilience.
- nih.gov
Suicidal behavior in schizoaffective disorder represents a high-risk psychiatric clinical state characterized by active or recurrent suicidal ideation, preparatory acts, and non-fatal or fatal intentional self-harm occurring in individuals diagnosed with schizoaffective disorder Pathophysiologically, this presentation stems from complex neurobiological dysregulation involving monoaminergic neurotransmission—most notably serotonergic and dopaminergic pathways—alongside frontolimbic network dysfun...
- mayoclinic.org
Suicidal behavior in schizoaffective disorder represents a high-risk psychiatric clinical state characterized by active or recurrent suicidal ideation, preparatory acts, and non-fatal or fatal intentional self-harm occurring in individuals diagnosed with schizoaffective disorder
- nih.gov
Affecting the central nervous system and behavioral regulation in individuals experiencing concurrent psychotic and major affective disturbances, it is clinically defined by severe depressive or mixed mood episodes interacting with psychotic phenomena, such as persecutory delusions or command hallucinations
- nih.gov
Affecting the central nervous system and behavioral regulation in individuals experiencing concurrent psychotic and major affective disturbances, it is clinically defined by severe depressive or mixed mood episodes interacting with psychotic phenomena, such as persecutory delusions or command hallucinations
- nih.gov
Pathophysiologically, this presentation stems from complex neurobiological dysregulation involving monoaminergic neurotransmission—most notably serotonergic and dopaminergic pathways—alongside frontolimbic network dysfunction that impairs impulse control, cognitive processing, and affective resilience
Personalize your experience
Follow Suicidal behavior in schizoaffective disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.